Esperion Therapeutics
ESPR
#6395
Rank
C$1.09 B
Marketcap
C$4.57
Share price
-0.30%
Change (1 day)
86.16%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2025 (TTM): C-$0.71

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is C-$0.68. In 2024 the company made an earnings per share (EPS) of C-$0.31 an increase over its 2023 EPS that were of C-$2.89.

EPS history for Esperion Therapeutics from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$0.71126.3%
2024C-$0.31-89.15%
2023C-$2.89-40.28%
2022C-$4.84-62.87%
2021C-$13.0480.38%
2020C-$7.2350.14%
2019C-$4.82-53.18%
2018C-$10.297.41%
2017C-$9.58110.81%
2016C-$4.5447.35%
2015C-$3.080.89%
2014C-$3.06

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$1.86-372.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$58.82-8,724.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
C-$8.10 1,088.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
C-$0.26-62.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
C-$0.15-78.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$3.71-644.00%๐Ÿ‡บ๐Ÿ‡ธ USA